| Financial Year |
March 31 2023 |
| Monetary Funds |
1,745,011,136.93 |
| Held-for-trading Financial Assets |
9,912,139.95 |
| Notes Receivable |
240,329,791.65 |
| Accounts Receivable |
1,055,345,332.88 |
| Advances to Suppliers |
147,753,126.90 |
| Other Receivables |
17,020,359.06 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,165,507,876.72 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
56,271,923.11 |
| Total Current Assets |
5,592,826,984.64 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,360,113,033.94 |
| Investment Properties |
-- |
| Fixed Assetes |
2,445,441,262.09 |
| Under-construction Projects |
266,020,868.97 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
369,854,285.52 |
| R&D expenses |
-- |
| Goodwill |
2,048,584.55 |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
24,077,241.56 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
4,525,536,266.68 |
| Total Assets |
10,118,363,251.32 |
| Short-Term Loans |
599,452,725.71 |
| Trading Financial liabilities |
-- |
| Notes Payable |
531,130,540.00 |
| Accounts Payable |
657,527,690.74 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
50,347,763.44 |
| Taxes Payable |
43,848,705.93 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
31,577,807.89 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
10,011,944.44 |
| Other Current Liabilities |
91,677,775.56 |
| Sub-Total of Current Liabilities |
2,914,205,740.13 |
| Long-term Loans |
215,203,972.23 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
21,372,746.95 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
525,524,962.23 |
| Total Liabilities |
3,439,730,702.36 |
| Paid-In Capital(Or Share Stock) |
977,170,720.00 |
| Capital Surplus |
1,835,423,955.43 |
| Surplus Reserve |
507,496,642.91 |
| LESS:Treasury Stock |
33,452,297.71 |
| Undistributed Profits |
3,186,272,384.04 |
| Minority Stockholder's Interest |
212,356,867.73 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,466,275,681.23 |
| Owner's Equity（Stockholder's Equity） |
6,678,632,548.96 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
10,118,363,251.32 |
